Search research articles
Contact Us
Filters
Showing results (71-80 of 179) with videos related to
Page
of 18
Sort By:
Leukemia & Lymphoma
|
May 30, 2024
White blood cell count nadir to zero following intensive chemotherapy as a predictive factor for patients with acute myeloid leukemia
Jacob Fang, Grace Bosma, Dara Aisner, et al.
Leukemia & Lymphoma
|
June 12, 2012
2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels
Daniel A Pollyea, Holbrook E Kohrt, Bing Zhang, et al.
Blood Advances
|
May 23, 2020
Adult cord blood transplant results in comparable overall survival and improved GRFS vs matched related transplant
Prashant Sharma, Enkhtsetseg Purev, Bradley Haverkos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2021
Project 2025: Proposals for the Continued Success of Drug Development in Acute Myeloid Leukemia
Daniel A Pollyea, John Barrett, Courtney D DiNardo, et al.
Haematologica
|
November 4, 2017
Randomized study of continuous high-dose lenalidomide, sequential azacitidine and lenalidomide, or azacitidine in persons 65 years and over with newly-diagnosed acute myeloid leukemia
Bruno C Medeiros, Kelly McCaul, Suman Kambhampati, et al.
Haematologica
|
March 9, 2019
Myelodysplastic syndrome-associated spliceosome gene mutations enhance innate immune signaling
Daniel A Pollyea, Chelsea Harris, Jennifer L Rabe, et al.
Haematologica
|
March 11, 2017
Targeted therapy for a subset of acute myeloid leukemias that lack expression of aldehyde dehydrogenase 1A1
Maura Gasparetto, Shanshan Pei, Mohammad Minhajuddin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 22, 2006
Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation
Andrew S Artz, Daniel A Pollyea, Masha Kocherginsky, et al.
Haematologica
|
December 18, 2012
Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia
Daniel A Pollyea, James Zehnder, Steve Coutre, et al.
European Journal of Haematology
|
May 31, 2023
Venetoclax-based salvage therapy for adult patients with relapsed/refractory acute lymphoblastic leukemia
Jonathan Canaani, Avraham Frisch, Daniel A Pollyea, et al.
Page
of 18
Search research articles
Search
Showing results (71-80 of 179) with videos related to
Sort By:
Page
of 18
Leukemia & Lymphoma
|
May 30, 2024
White blood cell count nadir to zero following intensive chemotherapy as a predictive factor for patients with acute myeloid leukemia
Jacob Fang, Grace Bosma, Dara Aisner, et al.
Leukemia & Lymphoma
|
June 12, 2012
2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels
Daniel A Pollyea, Holbrook E Kohrt, Bing Zhang, et al.
Blood Advances
|
May 23, 2020
Adult cord blood transplant results in comparable overall survival and improved GRFS vs matched related transplant
Prashant Sharma, Enkhtsetseg Purev, Bradley Haverkos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2021
Project 2025: Proposals for the Continued Success of Drug Development in Acute Myeloid Leukemia
Daniel A Pollyea, John Barrett, Courtney D DiNardo, et al.
Haematologica
|
November 4, 2017
Randomized study of continuous high-dose lenalidomide, sequential azacitidine and lenalidomide, or azacitidine in persons 65 years and over with newly-diagnosed acute myeloid leukemia
Bruno C Medeiros, Kelly McCaul, Suman Kambhampati, et al.
Haematologica
|
March 9, 2019
Myelodysplastic syndrome-associated spliceosome gene mutations enhance innate immune signaling
Daniel A Pollyea, Chelsea Harris, Jennifer L Rabe, et al.
Haematologica
|
March 11, 2017
Targeted therapy for a subset of acute myeloid leukemias that lack expression of aldehyde dehydrogenase 1A1
Maura Gasparetto, Shanshan Pei, Mohammad Minhajuddin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 22, 2006
Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation
Andrew S Artz, Daniel A Pollyea, Masha Kocherginsky, et al.
Haematologica
|
December 18, 2012
Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia
Daniel A Pollyea, James Zehnder, Steve Coutre, et al.
European Journal of Haematology
|
May 31, 2023
Venetoclax-based salvage therapy for adult patients with relapsed/refractory acute lymphoblastic leukemia
Jonathan Canaani, Avraham Frisch, Daniel A Pollyea, et al.
Page
of 18